Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.7.0.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
Collaboration agreements $ 7,977 $ 3,592 $ 11,283 $ 7,303
Research grants 276 110 395 341
Total revenues 8,253 3,702 11,678 7,644
Operating expenses:        
Research and development 14,984 19,454 27,926 34,720
General and administrative 6,037 11,090 13,312 16,447
Total operating expenses 21,021 30,544 41,238 51,167
Loss from operations (12,768) (26,842) (29,560) (43,523)
Interest and other income, net 277 243 437 430
Loss before income taxes (12,491) (26,599) (29,123) (43,093)
Benefit from income taxes   24   24
Net loss $ (12,491) $ (26,575) $ (29,123) $ (43,069)
Basic and diluted net loss per share $ (0.17) $ (0.38) $ (0.41) $ (0.61)
Shares used in computing basic and diluted net loss per share 72,527 70,487 71,780 70,430